Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Mar 24;13(1):67.
doi: 10.1186/s12974-016-0530-x.

Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research

Affiliations
Review

Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research

Avinash Parimisetty et al. J Neuroinflammation. .

Abstract

First seen as a storage organ, the white adipose tissue (WAT) is now considered as an endocrine organ. WAT can produce an array of bioactive factors known as adipokines acting at physiological level and playing a vital role in energy metabolism as well as in immune response. The global effect of adipokines in metabolic activities is well established, but their impact on the physiology and the pathophysiology of the central nervous system (CNS) remains poorly defined. Adipokines are not only produced by the WAT but can also be expressed in the CNS where receptors for these factors are present. When produced in periphery and to affect the CNS, these factors may either cross the blood brain barrier (BBB) or modify the BBB physiology by acting on cells forming the BBB. Adipokines could regulate neuroinflammation and oxidative stress which are two major physiological processes involved in neurodegeneration and are associated with many chronic neurodegenerative diseases. In this review, we focus on four important adipokines (leptin, resistin, adiponectin, and TNFα) and one lipokine (lysophosphatidic acid-LPA) associated with autotaxin, its producing enzyme. Their potential effects on neurodegeneration and brain repair (neurogenesis) will be discussed. Understanding and regulating these adipokines could be an interesting lead to novel therapeutic strategy in order to counteract neurodegenerative disorders and/or promote brain repair.

Keywords: Adipocytokines; Central nervous system; Diabetes; Neurodegeneration; Neurogenesis; Neuroinflammation; Obesity; White adipose tissue.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Effects of the main adipokines on brain homeostasis/functions. LPA lisophosphatidic acid, TNFα tumor necrosis factor-α
Fig. 2
Fig. 2
Adipokines and LPA interactions with the blood brain barrier and the central nervous system. The BBB is composed of endothelial cells (displaying tight junctions), pericytes and astrocytes. a In physiological conditions, some adipokines such as leptin and TNFα can cross the BBB through different mechanisms and act on the central nervous system. b Adipokines can also activate endothelial cell receptors resulting in the modulation of the expression of tight junctions and in the modulation of the BBB permeability. In adiponectin case, one study reports its crossing through the BBB [191], while another indicates that it does not cross the BBB [138]. Both possibilities are shown. In inflammatory conditions, the BBB is leaking and could allow an increase passage of adipokines and LPA into the CNS, leading to an increase of oxidative stress and neurodegeneration (c)

References

    1. Awada R, Parimisetty A, Lefebvre d’Hellencourt C. Influence of obesity on neurodegenerative diseases. Neurodegener Dis. 2013;Chapter 16:381–401.
    1. World Health Organisation W: obesity and overweight. http://www.who.int/mediacentre/factsheets/fs311/en/. Accessed 22 Mar 2016.
    1. World Health Organisation W: diabetes. http://www.who.int/mediacentre/factsheets/fs312/en/. Accessed 22 Mar 2016.
    1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–53. doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S. - DOI - PubMed
    1. Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, Nag S, et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care. 2005;28:2130–5. - PubMed

Publication types

MeSH terms